-
Long-term Survival Update and Extended RAS Mutational Analysis of the CAIRO2 Trial: Addition of Cetuximab to CAPOX/Bevacizumab in Metastatic Colorectal Cancer
Study
EGAS50000000775
-
Angiopredict: predicting response for bevacizumab treatment
Study
EGAS00001002724
-
Somatic_mutation_and_clonal_evolution_in_the_human_bladder_WES_NOVASEQ
Study
EGAS00001003456
-
Multi-region RNA sequencing of tumour regions and tumour-adjacent normal lung tissue
Study
EGAS00001006517
-
Tracing early predictors of glioma evolution under therapy
Study
EGAS00001006894
-
Genomic characterization of metastatic breast cancers
Study
EGAS00001003290
-
Discovery of Non-ETS Gene Fusions in Human Prostate Cancer using Next Generation RNA Sequencing
Study
phs000310
-
IMPRESS: Improved methylation profiling using restriction enzymes and smMIP sequencing, combined with a new biomarker panel, creating a multi-cancer detection assay
Study
EGAS50000000624
-
Profiling Genome-Wide Circulating ncRNAs for the Early Detection of Lung Cancer
Study
phs004166
-
Elucidating the heterogeneity of immunotherapy response and immune-related toxicities by longitudinal ctDNA and immune cell compartment tracking in lung cancer
Study
EGAS00001007291